LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

Search

Certara Inc

Closed

SectorHealthcare

10.75 -1.83

Overview

Share price change

24h

Current

Min

10.38

Max

11.06

Key metrics

By Trading Economics

Income

-1.8M

4.7M

Sales

5.6M

106M

EPS

0.029

Profit margin

4.474

Employees

1,487

EBITDA

-25M

609K

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+32.97% upside

Dividends

By Dow Jones

Next Earnings

5 sie 2025

Market Stats

By TradingEconomics

Market Cap

-188M

1.9B

Previous open

12.58

Previous close

10.75

News Sentiment

By Acuity

50%

50%

164 / 381 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Certara Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

16 cze 2025, 22:33 UTC

Acquisitions, Mergers, Takeovers

KKR to Acquire Australian Power Provider Zenith Energy

16 cze 2025, 21:55 UTC

Major Market Movers

Geospace Technologies Shares Up on Petrobras Pact

16 cze 2025, 17:04 UTC

Major Market Movers

Roku Shares Climb on Advertising Deal with Amazon

16 cze 2025, 23:51 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16 cze 2025, 23:51 UTC

Market Talk

Nikkei May Trade Range Bound Amid Israel-Iran Conflict -- Market Talk

16 cze 2025, 23:41 UTC

Market Talk

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

16 cze 2025, 23:10 UTC

Market Talk
Acquisitions, Mergers, Takeovers

XRG Has 'Viable Path' to Approval of Santos Takeover -- Market Talk

16 cze 2025, 23:02 UTC

Market Talk

Auckland Airport Unlikely to Hit Target for International Passengers -- Market Talk

16 cze 2025, 22:32 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Santos Unlikely to Attract Rival Bidder to XRG -- Market Talk

16 cze 2025, 22:03 UTC

Acquisitions, Mergers, Takeovers

KKR & Co. to Buy Zenith Energy From Consortium Including Pacific Equity Partners, OPSEU Pension Trust, Foresight Group >KKR

16 cze 2025, 22:00 UTC

Acquisitions, Mergers, Takeovers

KKR Acquires Leading Australian Independent Power Producer Zenith Energy >KKR

16 cze 2025, 21:56 UTC

Earnings

Lennar Has an Earnings Miss. The Stock Slips. -- Barrons.com

16 cze 2025, 21:10 UTC

Acquisitions, Mergers, Takeovers

Mitsubishi in Talks to Sign $8 Billion Deal With Gas Producer Aethon -- WSJ

16 cze 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

16 cze 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

16 cze 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

16 cze 2025, 20:49 UTC

Market Talk

Fitch Revises Canadian Provinces Fiscal Outlook to 'Deteriorating' -- Market Talk

16 cze 2025, 20:14 UTC

Acquisitions, Mergers, Takeovers

Update: EchoStar Stock Surges. It's Short Covering and President Trump. -- Barrons.com

16 cze 2025, 20:13 UTC

Market Talk

Natural Gas Gains on Warmer Outlook -- Market Talk

16 cze 2025, 19:58 UTC

Acquisitions, Mergers, Takeovers

OpenAI and Microsoft Tensions Are Reaching a Boiling Point -- WSJ

16 cze 2025, 19:13 UTC

Market Talk

Middle-East Conflict May Not Push Up Oil Long Term -- Market Talk

16 cze 2025, 19:09 UTC

Market Talk

Amazon-Roku Deal Shows Competition for Streaming Ad Space -- Market Talk

16 cze 2025, 18:43 UTC

Market Talk

May Could Mark Nascent Recovery in Canada Housing Market -- Market Talk

16 cze 2025, 18:36 UTC

Market Talk

Soybeans May Get Boost from Renewable Fuel Obligations -- Market Talk

16 cze 2025, 18:29 UTC

Market Talk

Global Equities Roundup: Market Talk

16 cze 2025, 18:29 UTC

Market Talk

Shopify Appears More Resilient Than Feared -- Market Talk

16 cze 2025, 18:22 UTC

Market Talk

Citi Forecasts Downturn in Gold Futures -- Market Talk

16 cze 2025, 16:42 UTC

Market Talk

Homebuyers' Downpayments Are Shrinking For First Time in 2 Years -- Market Talk

16 cze 2025, 16:37 UTC

Market Talk

Big, Beautiful Bill Might Not Mean Big Growth -- Market Talk

16 cze 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

Peer Comparison

Price change

Certara Inc Forecast

Price Target

By TipRanks

32.97% upside

12 Months Forecast

Average 14.64 USD  32.97%

High 18 USD

Low 9 USD

Based on 9 Wall Street analysts offering 12 month price targets forCertara Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

9 ratings

3

Buy

6

Hold

0

Sell

Technical Score

By Trading Central

11.27 / 12.79Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Very Strong Bullish Evidence

Long Term

Strong Bullish Evidence

Sentiment

By Acuity

164 / 381 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Certara Inc

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.